학술논문
ChemoCentryx Appoints Anne-Marie S. Duliege, M.D., M.S. to Chief Strategic Development Role and Head of Immuno-Oncology
Document Type
News
Author
Source
GlobeNewswire. March 27, 2014
Subject
Language
English
Abstract
MOUNTAIN VIEW, Mar 27, 2014 (GLOBE NEWSWIRE via COMTEX) -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, announced today that it has [...]